Area of research
Infectious Diseases · Public Health, Environmental and Occupational Health
Research interest
Research interests include Mosquito-borne diseases and control, SARS-CoV-2 and COVID-19 Research, Viral Infections and Vectors, and Viral Infections and Outbreaks Research.
Peptide hormones and bile acids shaping immune tolerance of the liver: implications and applications.
<i>PRSSLY</i>-Based Molecular Sex Determination of Syrian Hamster (<i>Mesocricetus auratus</i>) Pups Using Placental Tissues.
COVID-19-related inflammation of the placenta impedes fetal development in pregnant hamsters
CD4<sup>+</sup> T cell-mediated immunity protects from VSV-SUD lethal challenge in a mouse model of Sudan virus infection.
Rational Design of a Chimpanzee Adenoviral-Vector Vaccine Against Yellow Fever Through the Modification of Antigen Transmembrane Domains.
Dengue virus harnesses mosquito Syntenin to load and secrete viral RNA into salivary exosomes.
Mission 2030: Toward universal hepatitis B immunization.
Optimization of YF17D-Vectored Zika Vaccine Production by Employing Small-Molecule Viral Sensitizers to Enhance Yields.
Immunological and transcriptomic profile of chimeric live-attenuated Zika vaccine linked to protection in non-human primates
T cell-mediated protection in absence of virus neutralizing antibodies.
YF17D-based vaccines - standing on the shoulders of a giant.
Multiplexed multicolor antiviral assay amenable for high-throughput research
GLP-1R agonist therapy and vaccine response: Neglected implications.
SeParate: multiway fluorescence-activated droplet sorting based on integration of serial and parallel triaging concepts.
Antigenic Imprinting Dominates Humoral Responses to New Variants of SARS-CoV-2 in a Hamster Model of COVID-19
Parallel Multifactorial Process Optimization and Intensification for High-Yield Production of Live YF17D-Vectored Zika Vaccine.
Polyfunctional immunity and transcriptional imprint associated with protection by chimeric live-attenuated Zika virus vaccine in non-human primates
Thymidine kinase-expressing yellow fever 17D reporter virus facilitates prodrug activation and bioorthogonal labelling of infected cells
Blocking NS3–NS4B interaction inhibits dengue virus in non-human primates
Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates.
YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge.
Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters.
<i>Ex vivo</i> gut cultures of <i>Aedes aegypti</i> are efficiently infected by mosquito-borne alpha- and flaviviruses.
Validation of a Reporter Cell Line for Flavivirus Inhibition Assays
Single-dose YF17D-vectored Ebola vaccine candidate protects mice against both lethal surrogate Ebola and yellow fever virus challenge
Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches
Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches.
The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters
The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters
Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters.